Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors
Conditions
- Pancreatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: erlotinib hydrochloride
- DRUG: gemcitabine hydrochloride
Sponsor
OSI Pharmaceuticals
Collaborators